$IPAR
INTERPARFUMS INC

2024 Q2 Form 10-Q Financial Statement

#000175392624000926 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $342.2M $324.0M $311.7M
YoY Change 10.67% 3.93% 24.35%
Cost Of Revenue $121.5M $121.6M $108.8M
YoY Change 0.52% 11.78% -2.38%
Gross Profit $220.8M $202.4M $203.0M
YoY Change 17.17% -0.28% 45.74%
Gross Profit Margin 64.51% 62.47% 65.11%
Selling, General & Admin $155.9M $134.4M $112.7M
YoY Change 16.9% 19.29% 44.38%
% of Gross Profit 70.63% 66.41% 55.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.002M $6.018M $4.115M
YoY Change 41.16% 46.25% 31.72%
% of Gross Profit 2.72% 2.97% 2.03%
Operating Expenses $155.9M $134.4M $112.7M
YoY Change 16.9% 19.29% 44.38%
Operating Profit $64.83M $67.97M $90.28M
YoY Change 17.82% -24.71% 47.47%
Interest Expense -$3.651M $1.807M $2.357M
YoY Change -260.41% -23.33% -2242.73%
% of Operating Profit -5.63% 2.66% 2.61%
Other Income/Expense, Net -$3.577M $2.080M $2.307M
YoY Change -887.89% -9.84% 1888.79%
Pretax Income $61.25M $70.05M $92.59M
YoY Change 10.41% -24.34% 51.23%
Income Tax $14.65M $16.75M $21.68M
% Of Pretax Income 23.92% 23.91% 23.41%
Net Earnings $36.82M $41.05M $54.07M
YoY Change 5.35% -24.08% 53.17%
Net Earnings / Revenue 10.76% 12.67% 17.34%
Basic Earnings Per Share $1.15 $1.28 $1.69
Diluted Earnings Per Share $1.14 $1.27 $1.68
COMMON SHARES
Basic Shares Outstanding 32.02M shares 32.02M shares 32.11M shares
Diluted Shares Outstanding 32.27K shares 32.27K shares 32.16K shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $76.71M $97.05M $237.8M
YoY Change -58.93% -59.18% -10.36%
Cash & Equivalents $38.97M $20.98M $149.1M
Short-Term Investments $37.74M $76.08M $88.70M
Other Short-Term Assets $23.62M $34.26M $20.35M
YoY Change -5.49% 68.38% -12.15%
Inventory $433.7M $400.2M $323.7M
Prepaid Expenses
Receivables $299.4M $293.1M $241.9M
Other Receivables $5.050M $5.581M $27.78M
Total Short-Term Assets $857.4M $832.7M $851.6M
YoY Change 4.12% -2.22% 15.95%
LONG-TERM ASSETS
Property, Plant & Equipment $161.1M $164.2M $169.0M
YoY Change -4.28% -2.88% -10.68%
Goodwill
YoY Change
Intangibles $282.4M $288.1M $294.3M
YoY Change -3.4% -2.1%
Long-Term Investments
YoY Change
Other Assets $20.45M $21.52M $25.83M
YoY Change -19.16% -16.67% -12.58%
Total Long-Term Assets $506.6M $516.5M $528.6M
YoY Change -4.09% -2.29% 23.58%
TOTAL ASSETS
Total Short-Term Assets $857.4M $832.7M $851.6M
Total Long-Term Assets $506.6M $516.5M $528.6M
Total Assets $1.364B $1.349B $1.380B
YoY Change 0.91% -2.25% 18.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $108.5M $106.2M $93.05M
YoY Change 19.19% 14.15% 28.23%
Accrued Expenses $145.1M $135.7M $190.3M
YoY Change -25.21% -28.71% 27.41%
Deferred Revenue
YoY Change
Short-Term Debt $18.49M $8.324M $18.00M
YoY Change 273.01% -53.76%
Long-Term Debt Due $28.74M $29.03M $29.09M
YoY Change -1.16% -0.22% 102.35%
Total Short-Term Liabilities $332.4M $302.5M $362.2M
YoY Change -2.7% -16.49% 44.74%
LONG-TERM LIABILITIES
Long-Term Debt $108.5M $115.9M $145.1M
YoY Change -21.71% -20.12% 15.95%
Other Long-Term Liabilities $21.87M $22.91M $23.30M
YoY Change -10.71% -1.7% -18.45%
Total Long-Term Liabilities $108.5M $115.9M $145.1M
YoY Change -21.71% -20.12% -5.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $332.4M $302.5M $362.2M
Total Long-Term Liabilities $108.5M $115.9M $145.1M
Total Liabilities $440.9M $418.4M $507.3M
YoY Change -8.19% -17.53% -12.18%
SHAREHOLDERS EQUITY
Retained Earnings $724.3M $711.0M $654.4M
YoY Change 8.15% 8.65%
Common Stock $32.00K $32.00K $32.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $52.86M $52.86M $43.06M
YoY Change 8.41% 22.78%
Treasury Stock Shares
Shareholders Equity $717.1M $708.1M $658.4M
YoY Change
Total Liabilities & Shareholders Equity $1.364B $1.349B $1.380B
YoY Change 0.91% -2.25% 18.76%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $36.82M $41.05M $54.07M
YoY Change 5.35% -24.08% 53.17%
Depreciation, Depletion And Amortization $6.002M $6.018M $4.115M
YoY Change 41.16% 46.25% 31.72%
Cash From Operating Activities $25.50M -$51.96M -$7.358M
YoY Change 80.56% 606.17% -69.27%
INVESTING ACTIVITIES
Capital Expenditures $1.330M $1.059M $2.415M
YoY Change 53.94% -56.15% -117.83%
Acquisitions
YoY Change
Other Investing Activities $37.91M $15.29M $64.21M
YoY Change -263.22% -76.19% 3592.35%
Cash From Investing Activities $36.58M $13.92M $61.64M
YoY Change -251.85% -77.42% -622.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $9.425M $9.397M
YoY Change 0.3% 114.59%
Cash From Financing Activities -43.88M -$28.13M -$12.56M
YoY Change -32.36% 124.06% -37.33%
NET CHANGE
Cash From Operating Activities 25.50M -$51.96M -$7.358M
Cash From Investing Activities 36.58M $13.92M $61.64M
Cash From Financing Activities -43.88M -$28.13M -$12.56M
Net Change In Cash 18.20M -$67.49M $44.34M
YoY Change -124.32% -252.19% -179.5%
FREE CASH FLOW
Cash From Operating Activities $25.50M -$51.96M -$7.358M
Capital Expenditures $1.330M $1.059M $2.415M
Free Cash Flow $24.17M -$53.02M -$9.773M
YoY Change 82.3% 442.5% -6.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000822663
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
70908000 usd
CY2023Q1 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
usd
CY2024Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
usd
CY2024Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
139000000
CY2024Q1 us-gaap Long Term Debt Term
LongTermDebtTerm
P10Y
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
120000000
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
80000000
CY2023Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
50000000
CY2022Q4 us-gaap Long Term Debt Term
LongTermDebtTerm
P4Y
CY2021Q2 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
120000000
CY2021Q2 us-gaap Long Term Debt Term
LongTermDebtTerm
P10Y
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M0D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
70053000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
92586000 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y1M24D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y4M2D
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
0-16469
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
INTER PARFUMS, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3275609
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
551 Fifth Avenue
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10176
CY2024Q1 dei City Area Code
CityAreaCode
(212)
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
983-2640
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $.001 par value per share
CY2024Q1 dei Trading Symbol
TradingSymbol
IPAR
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
20976000 usd
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32023640 shares
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
88462000 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
76078000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
94304000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
293075000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
247240000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
400209000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
371859000 usd
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
5581000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
7012000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
34258000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
29458000 usd
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2490000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
691000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
832667000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
839026000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
164165000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
169222000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26980000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28613000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
288117000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
296356000 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
15726000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
14545000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21521000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21567000 usd
CY2024Q1 us-gaap Assets
Assets
1349176000 usd
CY2023Q4 us-gaap Assets
Assets
1369329000 usd
CY2024Q1 us-gaap Loans Payable To Bank
LoansPayableToBank
8324000 usd
CY2023Q4 us-gaap Loans Payable To Bank
LoansPayableToBank
4420000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
29027000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
29587000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5928000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5951000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
106219000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
97409000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
135660000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
178880000 usd
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
17300000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
8498000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
302458000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
324745000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
115926000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
127897000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22905000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24517000 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32023640 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32004660 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
32000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
32000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
100309000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
98565000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
711043000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
693848000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-50417000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-40188000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
9981665 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
9981665 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
52864000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
52864000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
708103000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
699393000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
199784000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
192777000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
907887000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
892170000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1349176000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1369329000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
323963000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
311723000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
121578000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
108766000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
202385000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
202957000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
134412000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
112678000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
67973000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
90279000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
1807000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
2357000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
905000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-759000 usd
CY2024Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
3020000 usd
CY2023Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
5382000 usd
CY2024Q1 us-gaap Other Income
OtherIncome
-38000 usd
CY2023Q1 us-gaap Other Income
OtherIncome
41000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2080000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2307000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
70053000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
92586000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16750000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21678000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
53303000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
70908000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12255000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
16840000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
41048000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54068000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.28
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.69
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.27
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.68
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32041 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32018 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32266 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32159 shares
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.75
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.625
CY2024Q1 us-gaap Profit Loss
ProfitLoss
53303000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
70908000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
-956000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
-4166000 usd
CY2024Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-64000 usd
CY2023Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-1709000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14582000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13489000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
37829000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
81940000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12255000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
16840000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-228000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-206000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
5017000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3622000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
7010000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
20256000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
30819000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
61684000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
892170000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
788146000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
53303000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
907887000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
849607000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
53303000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
70908000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6018000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4115000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-153000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
220000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
589000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
633000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-32000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
41000 usd
CY2024Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1485000 usd
CY2023Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1324000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1461000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1188000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
24000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1518000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
50436000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
42670000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
34388000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
29688000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5245000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5640000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1468000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1293000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-27736000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-23327000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
7524000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
17771000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51960000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7358000 usd
CY2024Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
59619000 usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
42835000 usd
CY2024Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
74905000 usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
107045000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1059000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2415000 usd
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
305000 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
151000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13922000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
61644000 usd
CY2024Q1 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
4000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
17989000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
9425000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
9397000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1326000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4929000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
24032000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
20023000 usd
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
473000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
5580000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28131000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12555000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1317000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2611000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-67486000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
44342000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
88462000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
104713000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20976000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
149055000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
1127000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1563000 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
10479000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
4816000 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
151000000 usd
CY2024Q1 us-gaap Acquisition Costs
AcquisitionCosts
3100000 usd
CY2024Q1 us-gaap Escrow Deposit
EscrowDeposit
0 usd
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
129700000 usd
CY2024Q1 us-gaap Debt Instrument Interest Rate Terms
DebtInstrumentInterestRateTerms
one-month Euribor plus 0.75%
CY2024Q1 us-gaap Derivative Variable Interest Rate
DerivativeVariableInterestRate
0.02 pure
CY2024Q1 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.011 pure
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
178678000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
158733000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
221531000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
213126000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
400209000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
371859000 usd
CY2023Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
54100000 usd
CY2023Q1 us-gaap Derivative Swaption Interest Rate
DerivativeSwaptionInterestRate
0.02 pure
CY2021Q2 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
129700000 usd
CY2021Q2 us-gaap Derivative Swaption Interest Rate
DerivativeSwaptionInterestRate
0.011 pure
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.03 pure
CY2024Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000 usd
CY2023Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1400000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1500000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1300000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
0 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
0 usd
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
122100 shares
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
24.47
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
3140 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
11.86
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
118960 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
24.80
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
390000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
430000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.28
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
308970 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
86.52
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
140 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
73.09
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
18980 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
69.87
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
289850 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
87.62
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
170890 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
70.60
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
537505 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15700000 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
11900000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2700000 usd
CY2024Q1 us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
1326000 usd
CY2023Q1 us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
4929000 usd
CY2024Q1 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
220000 usd
CY2023Q1 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
780000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1375000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5403000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
41048000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54068000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32041 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32018 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
225 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
141 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32266 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32159 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.69
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.27
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.68
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
323963000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
311723000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
41048000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54068000 usd
CY2024Q1 us-gaap Assets
Assets
1349176000 usd
CY2023Q1 us-gaap Assets
Assets
1369329000 usd

Files In Submission

Name View Source Status
ipar-20240331_pre.xml Edgar Link unprocessable
0001753926-24-000926-index-headers.html Edgar Link pending
0001753926-24-000926-index.html Edgar Link pending
0001753926-24-000926.txt Edgar Link pending
0001753926-24-000926-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g084209_10q.htm Edgar Link pending
g084209_ex31-1.htm Edgar Link pending
g084209_ex31-2.htm Edgar Link pending
g084209_ex32-1.htm Edgar Link pending
g084209_ex32-2.htm Edgar Link pending
ipar-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ipar-20240331_cal.xml Edgar Link unprocessable
ipar-20240331_def.xml Edgar Link unprocessable
ipar-20240331_lab.xml Edgar Link unprocessable
g084209_10q_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending